Yucca Health review

A prescription package, rather than a complete coaching program

Yucca is worth comparing for someone who wants a cash-pay prescription service and can manage much of the routine through a patient portal. Its product pages include consultation, an injection kit and shipping, and the process describes online clinical review before dispensing. Those are useful service particulars. They do not establish scheduled one-to-one dietitian visits or a structured behavioral program. ^{[1] [2] [3]}

The portal can hold the treatment plan and progress record. That helps organize a prescription purchase, but a reader struggling with meals, activity or difficult weeks should compare the relevant professional support separately. I would choose this service for its defined prescribing package only if that is the job needed. A money-back slogan is a poor substitute for support someone already knows they will use.

Compare the actual support need in our guide to coaching and self-directed support.

The smaller monthly number can mean a bigger decision today

The current semaglutide listings are $89 monthly, $450 every six months and $828 every twelve months. Tirzepatide has corresponding charges of $139, $750 and $1,428. The annual semaglutide equivalent is $69 per month, but choosing that option means choosing the annual billing commitment. Put the actual invoice into the household budget before comparing monthly averages. ^{[1] [2]}

Yucca’s price lock attaches to a specific medication and billing cadence. Changing either starts a new plan at current pricing; cancellation or a lapse ends the lock. Pausing is described as preserving it. A stable price can be helpful, but it should not persuade someone to keep buying a plan that no longer suits their clinical needs or finances. ^[5]

Put the full invoice beside included services in the program-cost planner.

For a different support and pricing arrangement, read our Trava service-and-renewal review.

The refund promise becomes part of the weekly routine

The detailed six-month promise covers specified GLP-1 injectable plans started on or after September 18, 2026. It requires a starting weight, treatment as prescribed, dose confirmations within seventy-two hours and regular portal weights. It applies only when the final weight is no lower than the starting weight. Any weight loss means the no-results condition is not met; it is not a promise of a particular percentage reduction. ^[5]

The FAQ and full terms disagree about the required weekly-weight count and the effect of a pause: twenty of twenty-six versus eighteen of twenty-four, and lost eligibility versus an extended timeline. Get the governing rules resolved before purchase. Annual plans also require notice before the six-month mark rather than relying on the general thirty-day later claim window. Never continue medication against clinical advice to protect a possible refund. ^{[5] [6]}

For the role of a weight record outside a refund claim, read the evidence on self-weighing and feedback.

An easy cancellation button does not reverse every order

The ordinary refund policy makes prescription issuance the cutoff. Payment happens before clinical review; a declined prescription or cancellation before issuance receives a full refund. Once the prescription is issued, the ordinary order is final even if it has not shipped. The policy requests cancellation at least seven days before renewal, with a refund still possible if processing started but issuance has not occurred. ^[4]

I would compare the monthly option first when the reader is still deciding whether this service fits. Consider a longer plan only when its full charge and practical obligations remain acceptable without assuming a future refund. Yucca explicitly describes its medicines as compounded and not FDA-approved. The clinician’s treatment decision and any needed nutrition support deserve their own place in the plan. ^{[1] [2]}

For a different care and payment arrangement, compare our Nuform care-team and prepaid-plan review.

Understanding the cost

Advertised semaglutide options: $89 monthly, $450/six months or $828/twelve months. Tirzepatide: $139 monthly, $750/six months or $1,428/twelve months. Compare total cash due and renewal rather than the monthly equivalent alone; the selected clinical plan and current offer govern.